AN2728 (crisaborole)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AN2728 (crisaborole), covering 2017-03-06 to 2017-03-06. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of AN2728 Topical Ointment to Treat Adolescents With Atopic Dermatitis [Phase 2]